NURS 6630/Nurs 6630 midterm Exam. All Questioned Answered.
Buy and Download >
CLICK ON THE PRODUCT INFORMATION URL FOR MORE
NURS 6630/Nurs 6630 midterm Exam The PMHNP is selecting a medication treatment option for a patient who is exhibiting psychotic behaviors with poor impulse control and aggression. Of the available treatments, which can help temper some of the adverse effects or symptoms that are normally caused by O2 antagonism? The PMHNP is discussing dopamine D2 receptor occupancy and its association with aggressive behaviors in patients with the student. Why does the PMHNP prescribe A noncompliant patient states, “Why do you want me to put this poison in my body?” Identify the best response made by the psychiatric-mental health nurse practitioner (PMHNP). • Question 2 Ms. Hill is currently being treated for schizophrenia but has stopped taking her medications due to some side effects she claims she was experiencing. She presents to the clinic today with worsening symptoms. She is experiencing anhedonia, agitation, attentional impairment, and affective blunting. Which one of the symptoms mentioned is considered a positive symptom of schizophrenia? • Question 3 Which statement about neurotransmitters and medications is true? • Question 4 When an unstable patient asks why it is necessary to add medications to his current regimen, the PMHNP’s best response would be: • Question 5 During gene expression, what must occur prior to a gene being expressed? • Question 6 While genes have potential to modify behavior, behavior can also modify genes. How do genes impact this process? • Question 7 Though medications have the ability to target neurotransmitter release into the synapse by the presynaptic neuron it is not always necessary. The PMHNP understands that this is because: • Question 8 Why is the cytochrome P450 enzyme system of significance to the PMHNP? • Question 9 It is important for the PMHNP to recognize differences in pharmacokinetics to safely prescribe and monitor medications. Which of the following statements does the competent PMHNP identify as true? • Question 10 As it relates to G-protein linked receptors, what does the PMHNP understand about medications that are used in practice? • Question 11 The PMHNP is considering prescribing a 49-year-old male clozapine (Clozaril) to treat his schizophrenia and suicidal ideations. The PMHNP is aware that which factor may impact the dose needed to effectively treat his condition: • Question 12 A patient is diagnosed with bipolar disorder and is currently taking carbamazepine (Tegretol), aripiprazole (Abilify), and melatonin. The PMHNP has just written an order to discontinue the carbamazepine (Tegretol) for drug-induced thrombocytopenia. The PMHNP is aware that his next best action is to: • Question 13 A patient recently transferred following a suicide attempt has a history of schizophrenia, depression, and fibromyalgia. He is currently taking Amitriptyline (Elavil), Lisinopril, aspirin, and fluoxetine (Prozac). When assessing the psychiatric medications and the reason for admission, what would be the best course of action for the PMHNP with this client? • Question 14 A patient with schizophrenia is given an inverse agonist that acts on the receptor 5HT and neurotransmitter serotonin. What is the rationale for prescribing a medication such as this? • Question 15 The PMHNP is caring for four patients. Which patient statement indicates that benzodiazepines would be beneficial? • Question 16 Ms. Harlow is a 42-year-old patient who is prescribed a drug that acts on ionotropic receptors. She is curious about the effects of the drug and how it will act on her symptoms. Which statement made by the PMHNP demonstrates proper understanding of Ms. Harlow’s prescription? • Question 17 A patient is seeking pharmacological treatment for smoking cessation. Which drug class does the PMHNP prescribe to the patient? • Question 18 The PMHNP is caring for a new patient who has been transferred from another office. When meeting with the new patient, the patient reports, “I feel like I am improving with the stabilizers.” The PMHNP immediately recognizes that the patient is describing which kind of drug? • Question 19 A patient presents with frequent episodes of mania. Which statement describes an appropriate treatment approach for this patient? • Question 20 What characteristics do the nicotinic, cholinergic, serotonin 3, and glycine receptors all have in common? • Question 21 Which statement made by the patient suggests the patient will need to be treated with antipsychotics that target paranoid psychosis? • Question 22 Mr. McCullin is 64 years old with Parkinson’s disease. The PMHNP caring for Mr. McCullin wants to start him on a dopamine agonist to help manage and treat his condition. The PHMNP selects this agent because of which action it has on patients like Mr. McCullin? • Question 23 Mrs. Trevor is a 44-year-old patient who does not have a diagnosis of schizophrenia but occasionally reports symptoms of psychosis, followed by severe fatigue. Mrs. Trevor inquires about the use of amphetamines to help with her energy levels. Which response made by the PMHNP is most appropriate? • Question 24 The PMHNP is caring for a patient with schizophrenia and is considering a variety of treatment approaches. The PHMNP selects a viable treatment that is consistent with the “dopam